Caribou Biosciences Ownership | Who Owns Caribou Biosciences?
Caribou Biosciences Ownership Summary
Caribou Biosciences is owned by 64.25% institutional investors, 10.04% insiders, and 25.72% retail investors. Blackrock is the largest institutional shareholder, holding 7.78% of CRBU shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.92% of its assets in Caribou Biosciences shares.
CRBU Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Caribou Biosciences | 64.25% | 10.04% | 25.72% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 6.95M | 7.78% | $11.39M |
| Blackrock funding, inc. /de | 6.56M | 7.26% | $10.44M |
| Pfizer | 4.69M | 5.19% | $7.46M |
| Vanguard group | 4.57M | 5.05% | $7.26M |
| Bank of america corp /de/ | 4.16M | 4.66% | $6.83M |
| Pfm health sciences, lp | 3.88M | 4.29% | $6.16M |
| Jpmorgan chase | 2.50M | 2.76% | $3.97M |
| Kynam capital management, lp | 2.41M | 2.66% | $3.83M |
| Schonfeld strategic advisors | 2.11M | 2.34% | $3.36M |
| Elmwood wealth management | 2.03M | 2.24% | $3.22M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| 72 investment | 474.07K | 1.53% | $753.77K |
| Elmwood wealth management | 2.03M | 1.30% | $3.22M |
| Lynx1 capital management lp | 680.19K | 0.41% | $1.08M |
| Pfm health sciences, lp | 3.88M | 0.38% | $6.16M |
| Pfizer | 4.69M | 0.29% | $7.46M |
| Pale fire capital se | 734.20K | 0.26% | $1.17M |
| Green alpha advisors | 181.05K | 0.23% | $287.88K |
| Kynam capital management, lp | 2.41M | 0.23% | $3.83M |
| Bruce | 250.00K | 0.13% | $397.50K |
| Milestone asset management | 163.79K | 0.06% | $260.43K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Pfizer | 4.69M | 0.29% | 4.69M |
| Bank of america corp /de/ | 4.16M | 0.00% | 3.05M |
| Jpmorgan chase | 2.50M | 0.00% | 2.06M |
| Schonfeld strategic advisors | 2.11M | 0.02% | 467.74K |
| Two sigma advisers, lp | 1.47M | 0.01% | 416.60K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avidity partners management lp | - | - | -5.79M |
| Alkeon capital management | - | - | -2.74M |
| Paradigm biocapital advisors lp | - | - | -2.17M |
| Point72 asset management | 1.02M | 0.00% | -1.11M |
| Rokos capital management llp | - | - | -840.63K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Pfizer | 4.69M | 0.29% | 4.69M | $7.46M |
| Ameriprise financial | 408.06K | 0.00% | 408.06K | $648.81K |
| Susquehanna fundamental investments | 180.82K | 0.00% | 180.82K | $287.51K |
| Sei investments | 64.36K | 0.00% | 64.36K | $102.34K |
| Keystone financial group | 45.40K | 0.01% | 45.40K | $72.19K |
Sold Out
| Holder | Change |
|---|---|
| Nbc securities | -2.00 |
| Nelson, van denburg & campbell wealth management group | -17.00 |
| Daiwa securities group | -176.00 |
| Jamison private wealth management | -188.00 |
| Piscataqua savings bank | -250.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 133 | 2.31% | 58,115,660 | 10.96% | 64 | 1.92% | 73 | 21.67% | 27 | -15.63% |
| Sep 30, 2024 | 130 | -6.47% | 52,373,357 | -1.44% | 57 | 1.64% | 61 | -8.96% | 33 | -19.51% |
| Jun 30, 2024 | 139 | -10.32% | 53,138,330 | -20.38% | 59 | 1.04% | 67 | -8.22% | 41 | -6.82% |
| Mar 31, 2024 | 155 | 6.90% | 66,737,162 | -3.26% | 75 | 1.11% | 73 | -10.98% | 44 | 33.33% |
| Dec 31, 2023 | 145 | 10.69% | 68,986,888 | -2.47% | 82 | 0.62% | 82 | -2.38% | 33 | 57.14% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.70M | 2.92% | - |
| iShares Russell 2000 ETF | 2.22M | 2.39% | -19.25K |
| ACATIS Datini Valueflex Fonds A | 2.00M | 2.15% | - |
| Selectra J. Lamarck Biotech A | 1.50M | 1.61% | 400.00K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.23M | 1.33% | - |
| JPMorgan US Small Company L | 786.21K | 0.87% | -22.84K |
| iShares Russell 2000 Value ETF | 777.13K | 0.84% | - |
| Fidelity Small Cap Index | 753.19K | 0.81% | -14.11K |
| Candriam Global Equities Oncology | 625.00K | 0.69% | -520.00K |
| iShares Biotechnology ETF | 556.11K | 0.61% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 14, 2025 | Haurwitz Rachel E. | President and CEO | Buy | $20.40K |
| Feb 21, 2025 | MCCLUNG BARBARA G | Chief Legal Officer | Sell | $4.81K |
| Feb 21, 2025 | Khan Ruhi Ahmad | Chief Business Officer | Sell | $4.81K |
| Feb 21, 2025 | Kanner Steven | Chief Scientific Officer | Sell | $4.81K |
| Jan 29, 2025 | Ryali Sriram | Chief Financial Officer | Buy | $24.65K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | 1 | 3 |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q1 | - | - |
| 2023 Q2 | - | - |
CRBU Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools